322 related articles for article (PubMed ID: 27151884)
21. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
Redhead K; Watkins J; Barnard A; Mills KH
Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
[TBL] [Abstract][Full Text] [Related]
22. Outer membrane vesicles as acellular vaccine against pertussis.
Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
[TBL] [Abstract][Full Text] [Related]
23. T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.
Ausiello CM; Lande R; Stefanelli P; Fazio C; Fedele G; Palazzo R; Urbani F; Mastrantonio P
Clin Diagn Lab Immunol; 2003 Jul; 10(4):637-42. PubMed ID: 12853397
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
25. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
van den Berg BM; David S; Beekhuizen H; Mooi FR; van Furth R
Vaccine; 2000 Dec; 19(9-10):1118-28. PubMed ID: 11137247
[TBL] [Abstract][Full Text] [Related]
26. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
Mills KH; Ryan M; Ryan E; Mahon BP
Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
[TBL] [Abstract][Full Text] [Related]
27. Pertussis vaccines and protective immunity.
Kapil P; Merkel TJ
Curr Opin Immunol; 2019 Aug; 59():72-78. PubMed ID: 31078081
[TBL] [Abstract][Full Text] [Related]
28. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
Feunou PF; Kammoun H; Debrie AS; Locht C
Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
[TBL] [Abstract][Full Text] [Related]
29. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
30. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
[TBL] [Abstract][Full Text] [Related]
31. Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.
da Silva Antunes R; Quiambao LG; Soldevila F; Sutherland A; Peters B; Sette A
Cytokine; 2021 Jan; 137():155313. PubMed ID: 33002739
[TBL] [Abstract][Full Text] [Related]
32. PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model.
Li P; Asokanathan C; Liu F; Khaing KK; Kmiec D; Wei X; Song B; Xing D; Kong D
Int J Pharm; 2016 Nov; 513(1-2):183-190. PubMed ID: 27586408
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Boredetella pertussis as a Vaccine Candidate.
Soltani MS; Noofeli M; Banihashemi SR; Shahcheraghi F; Eftekhar F
Iran Biomed J; 2021 Nov; 25(6):399-407. PubMed ID: 34719226
[TBL] [Abstract][Full Text] [Related]
34. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
[TBL] [Abstract][Full Text] [Related]
35. Acellular and whole cell pertussis vaccines protect against the lethal effects of intracerebral challenge by two different T-cell dependent humoral routes.
Wiertz EJ; Walvoort HC; Van Loveren H; Van Straaten-Van De Kappelle I; Van Der Gun JW; Kreeftenberg JG
Biologicals; 1990 Jul; 18(3):173-80. PubMed ID: 2257130
[TBL] [Abstract][Full Text] [Related]
36. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T
Allen AC; Wilk MM; Misiak A; Borkner L; Murphy D; Mills KHG
Mucosal Immunol; 2018 Nov; 11(6):1763-1776. PubMed ID: 30127384
[TBL] [Abstract][Full Text] [Related]
37. Bordetella pertussis iron regulated proteins as potential vaccine components.
Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
[TBL] [Abstract][Full Text] [Related]
38. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
39. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
[TBL] [Abstract][Full Text] [Related]
40. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]